PTK2 and Parkinson disease: The fact that patients with PD+IR+ Down syndrome show decreased expression of the PTK2 gene, together with the inflammatory environment that characterises this group of patients, may cause FAK levels to be greatly reduced, since FAK is inactivated in the presence of inflammatory conditions, which implies lower differentiation of osteoblasts by direct action of a compromise in their adhesion [25].